Login

Julien Guerrand of TCM Capital and Martin Baumann, Co-Founder of CMCC Global, share insights as hedge fund and capital management leaders. 00:10:00

Share On Facebook Share On Twitter

Julien Guerrand of TCM Capital

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Discover What Sets Pathway Financial Advisors Apart in Their Latest Video
00:10:00
Financial Planner & Real Estate Investor: Meghan Chomut
00:10:00
V-Zug CEO Peter Spirig Discusses Company Vision and Innovations at Industry Event | Peter Spirig, CEO , V-Zug Holding AG.
00:10:00
From Football Dreams to Financial Planning: My Journey | Ben Geiger, Financial Planner of Syverson Strege
00:10:00
Cleary Gottlieb Receives 2016 Pro Bono Publico Award | Michael L. Ryan - Senior Counsel of Cleary Gottlieb Steen & Hamilton LLP
00:10:00
Invests in talented founders building the next generation of software giants|Mark Mullen,Co-Founder and General Partner,Bonfire Ventures
00:10:00
Exploring Clara Resources: Heavy Rare Earths for the Electric Future
00:10:00
The Bright Side of Venture Capital|Albert Wenger, Managing Partner,Union Square Ventures
00:10:00
Senior Advisor on Retirement Strategies at BlackRock
00:10:00
Jonathan Nelson on the Future of Media, Streaming, and Private Equity | Jonathan Nelson, CEO, Providence Equity Partners.
00:10:00
Brink’s CEO: Conditions for U.S. Marijuana Dispensary Partnership & Industry Opportunities | Douglas A Pertz - CEO of Brink's
00:10:00
Final Tips for Effective Online Training Sessions

© 2017 - Neuhu+